New developments in the management of partial-onset epilepsy: role of brivaracetam. - Wikidata - wikimedia - TriplyDB

New developments in the management of partial-onset epilepsy: role of brivaracetam.

New developments in the management of partial-onset epilepsy: role of brivaracetam.

http://www.wikidata.org/entity/Q37693757

about

Evaluation of brivaracetam: a new drug to treat epilepsy.

P2860

Q38652806-12AFDE26-CD56-407F-9415-B030796A949A

P2860

New developments in the management of partial-onset epilepsy: role of brivaracetam.

http://www.wikidata.org/entity/Q37693757

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 March 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

New developments in the management of partial-onset epilepsy: role of brivaracetam.

@en

New developments in the management of partial-onset epilepsy: role of brivaracetam.

@nl

type

label

New developments in the management of partial-onset epilepsy: role of brivaracetam.

@en

New developments in the management of partial-onset epilepsy: role of brivaracetam.

@nl

prefLabel

New developments in the management of partial-onset epilepsy: role of brivaracetam.

@en

New developments in the management of partial-onset epilepsy: role of brivaracetam.

@nl

P1433

Q37693757-D043A046-6DF8-4032-8D88-257A25E522E2

P1476

Q37693757-2AA625B3-9017-4014-8FCC-A332329D9F54

P2093

Q37693757-872A4124-B032-4225-B3C2-594D23765ABC

Q37693757-D9D9E4D2-F400-475D-B698-0B3A9DFF190F

Q37693757-FA8C2819-3141-4BBC-B05D-7C53A41EB6BB

P275

Q37693757-BBCC4D6E-0806-4A2C-B9DB-57596ABD8549

P2860

Q37693757-01B76A1C-2D41-4804-B7B7-544240D55F7A

Q37693757-06D22D09-F2BF-40DB-86AF-CF1E7626F3CC

Q37693757-0CCBDF06-8FCF-447D-860D-1C63E5A5432B

Q37693757-0D39B73C-40C4-49F3-9E2B-74A8C74F6991

Q37693757-176741A2-8116-4B33-876D-9A4629CC5451

Q37693757-1F375B3A-61F7-4BFB-9132-E712E71D7CE8

Q37693757-21D2C523-AF99-4930-A5A8-8EC889ED194F

Q37693757-21D908D7-6B19-4481-BD56-A309C26F58DD

Q37693757-253FE9A9-6C44-4805-AC3B-DBE4D46D77D2

Q37693757-2FB082ED-8372-467E-B75D-9750F8AC7262

P304

Q37693757-0D261185-0AA3-49D6-BEC4-2753F8C83993

P31

Q37693757-101913C8-12BC-40AA-B96C-DC39F4EA4858

Q37693757-FE9F3891-4D3D-40AB-AF16-FB46AFEACF66

P356

Q37693757-E6712AFD-6515-4B67-99D6-D9974944C1E7

P407

Q37693757-0881DCD5-D0C4-4816-A720-D11AAA4E08A7

P478

Q37693757-4015FAF3-2463-4B45-82B5-413D9FD59C44

P50

Q37693757-B5889C3A-E95B-45B5-A33F-97400E346A11

P5008

Q37693757-42C6CCC9-4B73-41B6-846C-556C59C375F8

P577

Q37693757-4999AEC0-422F-4B9E-B086-A151B47AC5A5

P698

Q37693757-47FA8378-5FE0-4998-BEBF-B133E71D8F30

P921

Q37693757-3D268233-B990-4C44-A1F8-F7D8A9F07C2E

P932

Q37693757-D3D2776F-585B-4941-A8DD-7AC101D9BCBA

P356

P1433

Drug Design, Development and Therapy

P1476

New developments in the management of partial-onset epilepsy: role of brivaracetam.

@en

P2093

Alberto Verrotti

http://www.w3.org/2001/XMLSchema#string

Francesca Felicia Operto

http://www.w3.org/2001/XMLSchema#string

Giulia Iapadre

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Clobazam as an add-on in the management of refractory epilepsy

Update on the role of eslicarbazepine acetate in the treatment of partial-onset epilepsy

A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology

Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: a randomized placebo-controlled trial

Pharmacokinetics and metabolism of 14C-brivaracetam, a novel SV2A ligand, in healthy subjects

The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after multiple increasing oral doses in healthy men

Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009

Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A.

Comparison of a New In-House and Three Published HLA-B*15:02 Screening Methods for Prevention of Carbamazepine-Induced Severe Drug Reactions

Conversion to lacosamide monotherapy in the treatment of focal epilepsy: results from a historical-controlled, multicenter, double-blind study

P304

643-657

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DDDT.S103468

http://www.w3.org/2001/XMLSchema#string

P407

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Giangennaro Coppola

P5008

P577

2017-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28293101

http://www.w3.org/2001/XMLSchema#string

P921

P932

5345986

http://www.w3.org/2001/XMLSchema#string